LVW Advisors LLC decreased its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 13.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,700 shares of the financial services provider’s stock after selling 1,631 shares during the period. LVW Advisors LLC’s holdings in MetLife were worth $876,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently modified their holdings of the company. MeadowBrook Investment Advisors LLC raised its stake in shares of MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after buying an additional 220 shares during the period. Carmichael Hill & Associates Inc. lifted its position in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after buying an additional 186 shares in the last quarter. Wolff Wiese Magana LLC lifted its position in shares of MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares in the last quarter. Peterson Financial Group Inc. purchased a new position in shares of MetLife during the 3rd quarter valued at about $30,000. Finally, Retirement Wealth Solutions LLC purchased a new position in shares of MetLife during the 4th quarter valued at about $32,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
MET has been the topic of a number of analyst reports. TD Cowen lifted their price objective on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday, November 27th. Piper Sandler lifted their price objective on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Barclays boosted their price target on MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, January 6th. Wells Fargo & Company lowered their price target on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a report on Tuesday, January 14th. Finally, JPMorgan Chase & Co. boosted their price target on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, MetLife currently has a consensus rating of “Moderate Buy” and an average target price of $89.92.
MetLife Stock Performance
NYSE:MET opened at $86.83 on Monday. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 1 year low of $64.61 and a 1 year high of $89.05. The stock’s 50 day simple moving average is $83.41 and its two-hundred day simple moving average is $79.47. The company has a market cap of $60.12 billion, a price-to-earnings ratio of 17.51, a PEG ratio of 0.59 and a beta of 1.07.
MetLife Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be paid a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date is Tuesday, February 4th. MetLife’s payout ratio is 43.95%.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- Are Penny Stocks a Good Fit for Your Portfolio?
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- 3 REITs to Buy and Hold for the Long Term
- Oilfield Leader SLB: An AI Name You Need to Know
- There Are Different Types of Stock To Invest In
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.